Aptar Pharma, a leading provider of innovative drug delivery systems, is pleased to exhibit our recent advancements at two upcoming Pharma events during April – Interphex 2018, New York City, April 17-19 and CPhI North America 2018, Philadelphia, April 24-26.
At both shows, Aptar Pharma will highlight the benefits of our state-of-the-art manufacturing facility expansion in Congers, New York. Find out from our experts how we have broadened our capabilities to continue to deliver solutions to your drug delivery challenges with a greater manufacturing presence in North America. Equipped with the latest technologies to meet growing quality requirements for regulated markets, our expanded site further supports Aptar Pharma’s extensive drug delivery solutions, including our Premium portfolio of injectable components.
CPhI North America
At our Aptar Pharma Booth No. 2104 at CPhI North America 2018, attendees will have the exclusive opportunity to discover more about an upcoming market innovation within Aptar Pharma’s Consumer Health Care portfolio. Our experts will be on hand to discuss this new enhancement to our Drug Delivery Systems range. Be one of the first to stop by to find out how our new technologies and features can support your drug formulation or consumer product.
Latitude®, Aptar Pharma’s novel side-actuated nasal spray device, will also be a highlighted innovation at CPhI North America. Designed to help improve patient ease-of-use and compliance with its ergonomics and intuitiveness, Latitude® is suitable for a wide range of patient applications, including self-administration and pediatrics. Learn from our experts at CPhI North America how we can support your brand differentiation.
CPhI North America 2018, which takes place from April 24-26, 2018 at the Pennsylvania Convention Center, Philadelphia, PA, USA connects 7,400 pharmaceutical professionals with the opportunity to network, source partners and learn about new trends and technologies across the entire supply chain.
Join us at Booth No. 2104, in the InnoPack Packaging Zone. Click here for more information on CPhI North America..
At Interphex 2018, Booth No. 1734, our Aptar Pharma experts will showcase our single shot nasal drug delivery device, Unit Dose System (UDS). UDS was designed to enable the systemic delivery of drugs without the need for injection or administration by a healthcare professional. Come and learn from our experts how Aptar Pharma can help you make a positive impact on patients’ lives with UDS – the delivery device for NARCAN®, the first and only FDA-approved nasal form of Naloxone used for the treatment of an opioid emergency.
Our Eye Care experts will demonstrate the benefits of Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD), the multidose dispenser for preservative-free ophthalmic preparations suitable for a wide range of viscosities. Talk to us at Interphex about how the OSD can enhance your formulation delivery.
Interphex 2018 takes place from April 17-19 at the Javits Center in New York City. As the premier pharmaceutical, biotechnology and medical device development and manufacturing exhibition, Interphex brings together like-minded professionals to share insights, knowledge and technology innovations.